US President Donald Trump has announced a 100% tariff on certain patented drugs, sparking concerns about access to life-saving medications. Companies that have signed a 'most favoured nation' pricing deal and are onshoring production in the US will be exempt from the tariff.

Companies that have signed a “most favoured nation” pricing deal and are actively building facilities in the U.S. to onshore production of patented pharmaceuticals and their ingredients will have a 0% tariff